You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › May › 18
PFS
70 days ago
The drugmaker's fianlimab-cemiplimab combination did not reach statistical significance in improving progression-free survival (PFS).
page 1 of 1